ArticleFrontiers in oncology2026
Influence of COVID-19 pandemic on colon cancer presentations.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: We assumed that patients would present during the pandemic with more advanced, more disseminated, and more symptomatic forms of colon cancer. Materials and methods: We did a retrospective observational study that analyzed the database of the General Surgery Department of a tertiary care center in Romania, analyzing information about the patients from their clinical charts. The study was conducted on 204 patients diagnosed with colon cancer, subdivided into the pre-pandemic group (2019) and the pandemic group (2020). The ages varied between 27 and 95 years old, male and female. We measured: age, gender, year of admission, tumor localization, admission reasons, colon cancer emergencies, post-operative colon cancer complications, endoscopic tumor characteristics, histopathologic result, concomitant colonoscopy finding, presence and sites of metastases, and discharge status. Results: The number of presentations was lower in the pandemic year, but non-significant. During the pandemic, patients presented more with abdominal bloating, infiltrative tumors, multiple metastases, especially peritoneal metastases, indicating a more advanced local disease. As for colon cancer emergencies, inferior digestive hemorrhage occurred more frequently, consistent with more locally aggressive tumor behavior. Conclusions: During the pandemic, more patients presented with more oncologically advanced forms of colon cancer, but the cancer-related in-hospital mortality was not influenced. While the pandemic did not increase overall emergency presentations or short-term mortality, it was associated with delayed diagnosis and a higher burden of locally advanced and metastatic colon cancer at presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.